Clinician vs Patient Reporting of Baseline and Postbaseline Symptoms for Adverse Event Assessment in Cancer Clinical Trials

MLA

Jeff A. Sloan, et al. “Clinician vs Patient Reporting of Baseline and Postbaseline Symptoms for Adverse Event Assessment in Cancer Clinical Trials.” JAMA Oncology, vol. 6, Mar. 2020, p. 437. EBSCOhost, https://doi.org/10.1001/jamaoncol.2019.5566.

APA

Jeff A. Sloan, Ethan Basch, Gita Thanarajasingam, Thomas M. Atkinson, Amylou C. Dueck, Daniel Satele, & Jacqueline M. Lafky. (2020). Clinician vs Patient Reporting of Baseline and Postbaseline Symptoms for Adverse Event Assessment in Cancer Clinical Trials. JAMA Oncology, 6, 437. https://doi.org/10.1001/jamaoncol.2019.5566

Chicago

Jeff A. Sloan, Ethan Basch, Gita Thanarajasingam, Thomas M. Atkinson, Amylou C. Dueck, Daniel Satele, and Jacqueline M. Lafky. 2020. “Clinician vs Patient Reporting of Baseline and Postbaseline Symptoms for Adverse Event Assessment in Cancer Clinical Trials.” JAMA Oncology 6 (March): 437. doi:10.1001/jamaoncol.2019.5566.